
OK here it is. Finally. My #ASH25 algorithm for Relapsed Myeloma: First Relapse. Discussed with @YiLinMDPhD @myelomaMD Give comments. I’m willing to adjust it based on your insights.
Larissa Brunaldi
44 posts

@larissabrunaldi
CAR T Cell Therapy Research Trainee @mayoclinic - Hematology, BMT and Cell Therapy. Views are my own

OK here it is. Finally. My #ASH25 algorithm for Relapsed Myeloma: First Relapse. Discussed with @YiLinMDPhD @myelomaMD Give comments. I’m willing to adjust it based on your insights.
















Check out abstract 1533 @ASCO #ASCO2023 for Teclistamab infusions in the outpatient setting with use of remote patient monitoring. @larissabrunaldi @YiLinMDPhD @jonaspaludo 👉23pt =155 infusions = 98% administered outpt (80% NEVER ADMITTED) ##HCSM #MedEd #mmsm #DigitalHealth




#ASCO23 abstract1533 suggests that hospital-based outpatient setting is feasible and safe for administering and monitoring CAR-T #TCellRx and bispecific TCE therapies. #mmsm #lymsm @Radhika_Bansl @YiLinMDPhD @jonaspaludo mayocl.in/43mnCDn





